Skip to main content

Advertisement

Log in

Altered expression of circadian clock genes in head and neck squamous cell carcinoma

  • Research Article
  • Published:
Tumor Biology

Abstract

Head and neck squamous cell carcinoma (HNSCC) means a group of cancers developed from the upper aerodigestive tract, and 90% of them are squamous cell carcinomas. HNSCC is the tenth most commonly diagnosed form of cancer in males worldwide, but it is the seventh most common cause of cancer-related death. The circadian clock regulates daily rhythmic variations in various physiologic processes including sleep and activity, appetite, hormone levels, metabolism, and gene expression. Many recent studies have demonstrated that the disruption of circadian rhythm is associated with cancer development and tumor progression, such as chronic myeloid leukemia, hepatocellular carcinoma, endometrial carcinoma, and breast cancer. However the direct links between aberrant circadian clock gene expression and human malignancies, including HNSCC, remain largely unknown. In this study, the expression profiles of nine circadian clock genes of cancer tissue and noncancerous part from 40 patients of HNSCC were investigated. The expression of PER1, PER2, PER3, CRY1, CRY2, CKIε, and BMAL1 showed significant downregulation in the cancer tissues (p < 0.005). Downregulated PER3, CRY2, and BMAL1 expression was correlated with more advanced cancer stages (p < 0.05). Downregulated PER3 and upregulated TIM expression correlated with larger tumor size (p < 0.05), and lower expression of PER3 correlated with deeper tumor invasion (p < 0.05). Poor survival was related to lower expression of PER1 (p < 0.05) and PER3 (p < 0.01). These results indicate a possible association of circadian clock gene, especially PER3, expression with the pathogenesis of HNSCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Mehanna H, Paleri V, West CM, Nutting C. Head and neck cancer-part 1: epidemiology, presentation, and preservation. Clin Otolaryngol. 2011;36(1):65–8. doi:10.1111/j.1749-4486.2010.02231.x.

    Article  PubMed  CAS  Google Scholar 

  2. Department of Health EY, Taiwan, R.O.C. Cancer Registry Annual Report in Taiwan Area, 2005; 2006.

  3. Massano J, Regateiro FS, Januario G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102(1):67–76. doi:10.1016/j.tripleo.2005.07.038.

    Article  PubMed  Google Scholar 

  4. Scully C, Field JK, Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol. 2000;36(3):256–63.

    Article  PubMed  CAS  Google Scholar 

  5. Li C, Hu Z, Lu J, Liu Z, Wang LE, El-Naggar AK, et al. Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck. Cancer. 2007;110(4):867–75. doi:10.1002/cncr.22861.

    Article  PubMed  CAS  Google Scholar 

  6. Kenanli E, Karaman E, Enver O, Ulutin T, Buyru N. Genetic alterations of the LKB1 gene in head and neck cancer. DNA Cell Biol. 2010;29(12):735–8. doi:10.1089/dna.2010.1060.

    Article  PubMed  CAS  Google Scholar 

  7. Young MW, Kay SA. Time zones: a comparative genetics of circadian clocks. Nat Rev Genet. 2001;2(9):702–15. doi:10.1038/35088576;35088576.

    Article  PubMed  CAS  Google Scholar 

  8. Balsalobre A. Clock genes in mammalian peripheral tissues. Cell Tissue Res. 2002;309(1):193–9. doi:10.1007/s00441-002-0585-0.

    Article  PubMed  CAS  Google Scholar 

  9. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer. 2003;3(5):350–61. doi:10.1038/nrc1072;nrc1072.

    Article  PubMed  CAS  Google Scholar 

  10. Reppert SM, Weaver DR. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol. 2001;63:647–76. doi:10.1146/annurev.physiol.63.1.647;63/1/647.

    Article  PubMed  CAS  Google Scholar 

  11. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature. 2002;418(6901):935–41. doi:10.1038/nature00965;nature00965.

    Article  PubMed  CAS  Google Scholar 

  12. Strayer CA, Kay SA. The ins and outs of circadian regulated gene expression. Curr Opin Plant Biol. 1999;2(2):114–20. doi:10.1016/S1369-5266(99)80023-5.

    Article  PubMed  CAS  Google Scholar 

  13. Filipski E, King VM, Li X, Granda TG, Mormont MC, Liu X, et al. Host circadian clock as a control point in tumor progression. J Natl Cancer Inst. 2002;94(9):690–7.

    PubMed  Google Scholar 

  14. Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci. 2003;4(8):649–61. doi:10.1038/nrn1177;nrn1177.

    Article  PubMed  CAS  Google Scholar 

  15. Stevens RG. Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology. 2005;16(2):254–8.

    Article  PubMed  Google Scholar 

  16. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst. 2001;93(20):1563–8.

    Article  PubMed  CAS  Google Scholar 

  17. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst. 2003;95(11):825–8.

    Article  PubMed  Google Scholar 

  18. Zhu Y, Zheng T, Stevens RG, Zhang Y, Boyle P. Does "clock" matter in prostate cancer? Cancer Epidemiol Biomarkers Prev. 2006;15(1):3–5. doi:10.1158/1055-9965.EPI-05-0631.

    Article  PubMed  CAS  Google Scholar 

  19. Lin YM, Chang JH, Yeh KT, Yang MY, Liu TC, Lin SF, et al. Disturbance of circadian gene expression in hepatocellular carcinoma. Mol Carcinog. 2008;47(12):925–33. doi:10.1002/mc.20446.

    Article  PubMed  CAS  Google Scholar 

  20. Mormont MC, Waterhouse J, Bleuzen P, Giacchetti S, Jami A, Bogdan A, et al. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res. 2000;6(8):3038–45.

    PubMed  CAS  Google Scholar 

  21. Lee CC. Tumor suppression by the mammalian period genes. Cancer Causes Control. 2006;17(4):525–30. doi:10.1007/s10552-005-9003-8.

    Article  PubMed  Google Scholar 

  22. Yang MY, Chang JG, Lin PM, Tang KP, Chen YH, Lin HY, et al. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3. Cancer Sci. 2006;97(12):1298–307. doi:10.1111/j.1349-7006.2006.00331.x.

    Article  PubMed  CAS  Google Scholar 

  23. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis. 2005;26(7):1241–6. doi:10.1093/carcin/bgi075.

    Article  PubMed  CAS  Google Scholar 

  24. Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL. Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. Neoplasia. 2007;9(10):797–800.

    Article  PubMed  CAS  Google Scholar 

  25. Shih HC, Choo KB, Chang TJ, Yang MY, Shih MC, Yeh KT, et al. Disturbance of circadian gene expression in endometrial cancer: detection by real-time quantitative RT-PCR. Oncol Rep. 2005;14(6):1533–8.

    PubMed  CAS  Google Scholar 

  26. Lee JH, Sancar A. Regulation of apoptosis by the circadian clock through NF-{kappa}B signaling. Proc Natl Acad Sci USA. 2011. doi:10.1073/pnas.1108125108.

  27. Zeng ZL, Wu MW, Sun J, Sun YL, Cai YC, Huang YJ, et al. Effects of the biological clock gene Bmal1 on tumour growth and anti-cancer drug activity. J Biochem. 2010;148(3):319–26. doi:10.1093/jb/mvq069.

    Article  PubMed  CAS  Google Scholar 

  28. Sato F, Wu Y, Bhawal UK, Liu Y, Imaizumi T, Morohashi S, et al. PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells. Eur J Cancer. 2011;47(11):1747–58. doi:10.1016/j.ejca.2011.02.025.

    Article  PubMed  CAS  Google Scholar 

  29. Shearman LP, Jin X, Lee C, Reppert SM, Weaver DR. Targeted disruption of the mPer3 gene: subtle effects on circadian clock function. Mol Cell Biol. 2000;20:6269–75.

    Article  PubMed  CAS  Google Scholar 

  30. Zhu Y, Brown HN, Zhang Y, Stevens RG, Zheng T. Period3 structural variation: a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers Prev. 2005;14(1):268–70.

    PubMed  CAS  Google Scholar 

  31. Hrushesky WJ, Lannin D, Haus E. Evidence for an ontogenetic basis for circadian coordination of cancer cell proliferation. J Natl Cancer Inst. 1998;90(19):1480–4.

    Article  PubMed  CAS  Google Scholar 

  32. Granda TG, Levi F. Tumor-based rhythms of anticancer efficacy in experimental models. Chronobiol Int. 2002;19(1):21–41.

    Article  PubMed  CAS  Google Scholar 

  33. Yu EA, Weaver DR. Disrupting the circadian clock: gene-specific effects on aging, cancer, and other phenotypes. Aging (Albany NY). 2011;3(5):479–93.

    CAS  Google Scholar 

  34. Khapre RV, Samsa WE, Kondratov RV. Circadian regulation of cell cycle: molecular connections between aging and the circadian clock. Ann Med. 2010;42(6):404–15. doi:10.3109/07853890.2010.499134.

    Article  PubMed  CAS  Google Scholar 

  35. Yagita K, Horie K, Koinuma S, Nkamura W, Yamanaka I, Urasaki A, et al. Development of the circadian oscillator during differentiation of mouse embryonic stem cells in vitro. Proc Natl Acad Sci USA. 2010;107(8):3846–51.

    Article  PubMed  CAS  Google Scholar 

  36. Liu Y, Clem B, Zuba-Surma EK, El-Naggar S, Telang S, Jenson AB, et al. Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype. Cell Stem Cell. 2009;4(4):336–47.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Sheng-Fung Lin or Ming-Yu Yang.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Table S1

Oligonucleotide primers and probes for real-time quantitative RT-PCR analysis of the nine circadian clock genes. F forward primer, P probe, R reverse primer (DOC 50 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hsu, CM., Lin, SF., Lu, CT. et al. Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumor Biol. 33, 149–155 (2012). https://doi.org/10.1007/s13277-011-0258-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-011-0258-2

Keywords

Navigation